These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 38969094)
21. Gut Microbiota and Alcoholic Liver Disease. Scarpellini E; Forlino M; Lupo M; Rasetti C; Fava G; Abenavoli L; De Santis A Rev Recent Clin Trials; 2016; 11(3):213-9. PubMed ID: 27515958 [TBL] [Abstract][Full Text] [Related]
22. Roles of Gut Microbiota in Alcoholic Liver Disease. Zhang D; Liu Z; Bai F Int J Gen Med; 2023; 16():3735-3746. PubMed ID: 37641627 [TBL] [Abstract][Full Text] [Related]
23. Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction. Shao T; Zhao C; Li F; Gu Z; Liu L; Zhang L; Wang Y; He L; Liu Y; Liu Q; Chen Y; Donde H; Wang R; Jala VR; Barve S; Chen SY; Zhang X; Chen Y; McClain CJ; Feng W J Hepatol; 2018 Oct; 69(4):886-895. PubMed ID: 29803899 [TBL] [Abstract][Full Text] [Related]
25. Alcoholic liver disease: the gut microbiome and liver cross talk. Hartmann P; Seebauer CT; Schnabl B Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593 [TBL] [Abstract][Full Text] [Related]
26. Nutritional and microbiota-based therapeutic interventions for alcohol-associated liver disease: From pathogenesis to therapeutic insights. Rangra S; Rana D; Prajapati A; Benival D; Dwivedi P; Mandoli A Life Sci; 2024 Sep; 352():122852. PubMed ID: 38909682 [TBL] [Abstract][Full Text] [Related]
27. Zhong X; Cui P; Jiang J; Ning C; Liang B; Zhou J; Tian L; Zhang Y; Lei T; Zuo T; Ye L; Huang J; Chen H Front Cell Infect Microbiol; 2021; 11():649060. PubMed ID: 33816353 [TBL] [Abstract][Full Text] [Related]
28. Alcohol, liver disease and the gut microbiota. Bajaj JS Nat Rev Gastroenterol Hepatol; 2019 Apr; 16(4):235-246. PubMed ID: 30643227 [TBL] [Abstract][Full Text] [Related]
29. The Beneficial Effects of Natural Extracts and Bioactive Compounds on the Gut-Liver Axis: A Promising Intervention for Alcoholic Liver Disease. Zhao L; Wang S; Zhang N; Zhou J; Mehmood A; Raka RN; Zhou F; Zhao L Antioxidants (Basel); 2022 Jun; 11(6):. PubMed ID: 35740108 [TBL] [Abstract][Full Text] [Related]
30. Compound Probiotic Ameliorates Acute Alcoholic Liver Disease in Mice by Modulating Gut Microbiota and Maintaining Intestinal Barrier. Liu H; Kang X; Yang X; Yang H; Kuang X; Ren P; Yan H; Shen X; Kang Y; Li L; Wang X; Guo L; Tong M; Fan W Probiotics Antimicrob Proteins; 2023 Feb; 15(1):185-201. PubMed ID: 36456838 [TBL] [Abstract][Full Text] [Related]
31. Microbiota, a key player in alcoholic liver disease. Cassard AM; Ciocan D Clin Mol Hepatol; 2018 Jun; 24(2):100-107. PubMed ID: 29268595 [TBL] [Abstract][Full Text] [Related]
32. Pectin in Metabolic Liver Disease. Hu W; Cassard AM; Ciocan D Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615814 [TBL] [Abstract][Full Text] [Related]
33. Histopathological Features and Composition of Gut Microbiota in Rhesus Monkey of Alcoholic Liver Disease. Wang H; Yan Y; Yi X; Duan Y; Wang J; Li S; Luo L; Huang T; Inglis B; Li X; Ji W; Tan T; Si W Front Microbiol; 2019; 10():165. PubMed ID: 30800107 [TBL] [Abstract][Full Text] [Related]
35. Alcoholic liver disease: focus on prodromal gut health. Park B; Lee HR; Lee YJ J Dig Dis; 2016 Aug; 17(8):493-500. PubMed ID: 27356233 [TBL] [Abstract][Full Text] [Related]
36. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease. Woodhouse CA; Patel VC; Singanayagam A; Shawcross DL Aliment Pharmacol Ther; 2018 Jan; 47(2):192-202. PubMed ID: 29083037 [TBL] [Abstract][Full Text] [Related]
37. Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature. Milosevic I; Vujovic A; Barac A; Djelic M; Korac M; Radovanovic Spurnic A; Gmizic I; Stevanovic O; Djordjevic V; Lekic N; Russo E; Amedei A Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658519 [TBL] [Abstract][Full Text] [Related]
38. Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans. Maccioni L; Gao B; Leclercq S; Pirlot B; Horsmans Y; De Timary P; Leclercq I; Fouts D; Schnabl B; Stärkel P Gut Microbes; 2020 Nov; 12(1):1782157. PubMed ID: 32588725 [TBL] [Abstract][Full Text] [Related]
39. Sea buckthorn (Hippophae rhamnoides L.) fermentation liquid protects against alcoholic liver disease linked to regulation of liver metabolome and the abundance of gut microbiota. Ran B; Guo CE; Li W; Li W; Wang Q; Qian J; Li H J Sci Food Agric; 2021 May; 101(7):2846-2854. PubMed ID: 33145761 [TBL] [Abstract][Full Text] [Related]
40. Gut Microbiome-Centered Therapies for Alcohol-Associated Liver Disease. Ranjbarian T; Schnabl B Semin Liver Dis; 2023 Aug; 43(3):311-322. PubMed ID: 37527781 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]